Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Dresske

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|October 2, 2003
[Significance of allopeptide-induced expression of Fas ligand (FasL) in parenchyma of allogenic heart transplants as the cause of donor-specific tolerance induction]B Dresske, J Schröder, N Zavazava, et al.
Transplant Immunology|May 26, 1999
WOFIE augments the immunosuppressive potency of FK-506. Window of opportunity for immunological engagementB Dresske, N Zavazava, D S Huang, et al.
Journal of Leukocyte Biology|January 14, 1999
Different in vivo tolerogenicity of MHC class I peptidesF Fändrich, X Zhu, J Schröder, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|August 10, 2010
[Living donation liver transplantation in children]B Dresske, M Schulze, F Braun, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2006
Multipotent cells of monocytic origin improve damaged heart functionB Dresske, N E El Mokhtari, H Ungefroren, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Langenbecks Archiv Fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft Fur Chirurgie. Kongress|October 2, 2003
[Significance of allopeptide-induced expression of Fas ligand (FasL) in parenchyma of allogenic heart transplants as the cause of donor-specific tolerance induction]B Dresske, J Schröder, N Zavazava, et al.
Transplant Immunology|May 26, 1999
WOFIE augments the immunosuppressive potency of FK-506. Window of opportunity for immunological engagementB Dresske, N Zavazava, D S Huang, et al.
Journal of Leukocyte Biology|January 14, 1999
Different in vivo tolerogenicity of MHC class I peptidesF Fändrich, X Zhu, J Schröder, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|August 10, 2010
[Living donation liver transplantation in children]B Dresske, M Schulze, F Braun, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 14, 2006
Multipotent cells of monocytic origin improve damaged heart functionB Dresske, N E El Mokhtari, H Ungefroren, et al.
Pageof 1